Skip to main content
Premium Trial:

Request an Annual Quote

Protein Pathways Gets $100,000 SBIR Grant

Premium

L

OS ANGELES--Protein Pathways received a $100,000 SBIR phase I grant from the US National Institutes of Health to assign functions, using computational methods, to more than 1,500 genes from the Mycobacterium tuberculosis genome. Of the nearly 4,000 genes in the completely sequenced TB genome, greater than 40 percent have no associated functional information or sequence homology to proteins of known function. The company's functional analyses will identify genes essential for viability or virulence as antibiotic targets. The methods will provide rational targets in new antibiotic classes, as well as supplement currently targeted pathways. Information contained in fully sequenced prokaryotic and eukaryotic genomes offers the opportunity to develop novel anti-infective agents.

Filed under

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.